5/13/11 Contest Update
Was it Friday the 13th that spooked investors or the thought of Newt Gingrich becoming the Republican presidential nominee? Whatever the reason, despite a down Friday, biotechs actually managed to close the week higher.
At Friday’s close, the Nasdaq Biotech Index was up 16.65% YTD (vs. up 14.12% YTD a week ago) and the Contest median was up 11.81% YTD (vs. up 9.82% YTD a week ago). The Nasdaq Composite Index was up 6.62% YTD (vs. up 6.58% YTD a week ago).
Contest leader MCBIO’s portfolio (up 41.42% YTD) pulled away from the competition, with CRAZYP’s portfolio (up 36.68% YTD) and ROCKY’s portfolio (up 34.52% YTD) in second and third place..
At Friday's close, an impressive 34 of the 38 Contest portfolios were in the black with 14 of the 38 beating the high-flying NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a peaceful weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
5/13/11
Rank Name Profit/Loss
1 MCBIO 41,417
2 CRAZYP 36,678
3 ROCKY 34,523
4 FIB 32,776
5 RRGE 32,386
6 GENE 29,327
7 GHMM 27,262
8 RKRW 26,530
9 IJF 26,037
10 IMAN 23,202
Week's Top 5 Gainers
Symbol 5/6 5/13 % change
ONTY 4.47 5.91 32.21%
DSCO 1.91 2.50 30.89%
TSRX 5.94 7.69 29.46%
VICL 3.69 4.59 24.39%
ALKS 14.47 17.76 22.70%
Week's Top 5 Losers
Symbol 5/6 5/13 % change
BMTI 13.29 8.11 -39.01%
MRNA 0.54 0.45 -16.82%
ALTH 2.80 2.52 -10.00%
ITMN 42.92 39.20 -8.67%
PSDV 4.20 3.85 -8.33% |
